Site-specific molecular signatures predict aggressive disease in HNSCC

Thomas J Belbin1, Nicolas F Schlecht, Richard V Smith

  • 1Department of Pathology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA. tbelbin@aecom.yu.edu

Summary

Gene expression profiling in head and neck squamous cell carcinomas (HNSCC) reveals site-specific signatures. Anatomic location significantly influences outcome predictions, impacting aggressive versus non-aggressive disease classification.

Related Concept Videos